{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:50:19Z","timestamp":1791219019730,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1093\/intimm\/12.12.1749","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:50:44Z","timestamp":1027723844000},"page":"1749-1757","source":"Crossref","is-referenced-by-count":75,"title":["Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4"],"prefix":"10.1093","volume":"12","author":[{"given":"Joan","family":"Say\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuong B.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Stepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Schatzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Biron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cox","family":"Terhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,12]]},"reference":[{"key":"key\n\t\t\t\t20170710085140_R1","doi-asserted-by":"crossref","unstructured":"Purtilo, D. T., Cassel, C. K., Yang, J. P. and Harper, R. 1975. X-linked progressive combined variable immunodeficiency (Duncan's disease). Lanceti:935.","DOI":"10.1016\/S0140-6736(75)92004-8"},{"key":"key\n\t\t\t\t20170710085140_R2","doi-asserted-by":"crossref","unstructured":"Purtilo, D. T. 1991. X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology. Springer Semin. Immunopathol.13:181.","DOI":"10.1007\/BF00201468"},{"key":"key\n\t\t\t\t20170710085140_R3","doi-asserted-by":"crossref","unstructured":"Purtilo, D. T. 1980. Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lanceti:300.","DOI":"10.1016\/S0140-6736(80)90792-8"},{"key":"key\n\t\t\t\t20170710085140_R4","doi-asserted-by":"crossref","unstructured":"Seemayer, T. A., Gross, T. G., Egeler, R. M., Pirruccello, S. J., Davis, J. R., Kelly, C. M., Okano, M., Lanyi, A. and Sumegi, J. 1995. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res.38:471.","DOI":"10.1203\/00006450-199510000-00001"},{"key":"key\n\t\t\t\t20170710085140_R5","doi-asserted-by":"crossref","unstructured":"Maia, D. M. and Garwacki, C. P. 1999. X-linked lymphoproliferative disease: pathology and diagnosis. Pediatr Dev. Pathol.2:72.","DOI":"10.1007\/s100249900093"},{"key":"key\n\t\t\t\t20170710085140_R6","doi-asserted-by":"crossref","unstructured":"Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., Oettgen, H., De Vries, J. E., Aversa, G. and Terhorst, C. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature395:462.","DOI":"10.1038\/26683"},{"key":"key\n\t\t\t\t20170710085140_R7","doi-asserted-by":"crossref","unstructured":"Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C. J., Dunham, A., Rhodes, S., et al.1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet.20:129.","DOI":"10.1038\/2424"},{"key":"key\n\t\t\t\t20170710085140_R8","doi-asserted-by":"crossref","unstructured":"Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A. J., Wise, C., Ashley, J., Lovett, M., Valentine, M. B., Look, A. T., Gerald, W., Housman, D. E. and Haber, D. A. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA95:13765.","DOI":"10.1073\/pnas.95.23.13765"},{"key":"key\n\t\t\t\t20170710085140_R9","doi-asserted-by":"crossref","unstructured":"Cocks, B. G., Chang, C. C., Carballido, J. M., Yssel, H., de Vries, J. E. and Aversa, G. 1995. A novel receptor involved in T-cell activation. Nature376:260.","DOI":"10.1038\/376260a0"},{"key":"key\n\t\t\t\t20170710085140_R10","unstructured":"Aversa, G., Chang, C. C., Carballido, J. M., Cocks, B. G. and de Vries, J. E. 1997. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol.158:4036."},{"key":"key\n\t\t\t\t20170710085140_R11","doi-asserted-by":"crossref","unstructured":"Aversa, G., Carballido, J., Punnonen, J., Chang, C. C., Hauser, T., Cocks, B. G. and De Vries, J. E. 1997. SLAM and its role in T cell activation and Th cell responses. Immunol. Cell Biol.75:202.","DOI":"10.1038\/icb.1997.30"},{"key":"key\n\t\t\t\t20170710085140_R12","doi-asserted-by":"crossref","unstructured":"Carballido, J. M., Aversa, G., Kaltoft, K., Cocks, B. G., Punnonen, J., Yssel, H., Thestrup-Pedersen, K. and de Vries, J. E. 1997. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J. Immunol.159:4316.","DOI":"10.4049\/jimmunol.159.9.4316"},{"key":"key\n\t\t\t\t20170710085140_R13","doi-asserted-by":"crossref","unstructured":"Punnonen, J., Cocks, B. G., Carballido, J. M., Bennett, B., Peterson, D., Aversa, G. and de Vries, J. E. 1997. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med.185:993.","DOI":"10.1084\/jem.185.6.993"},{"key":"key\n\t\t\t\t20170710085140_R14","doi-asserted-by":"crossref","unstructured":"Argov, S., Johnson, D. R., Collins, M., Koren, H. S., Lipscomb, H. and Purtilo, D. T. 1986. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome. Cell Immunol100:1.","DOI":"10.1016\/0008-8749(86)90001-8"},{"key":"key\n\t\t\t\t20170710085140_R15","doi-asserted-by":"crossref","unstructured":"Sullivan, J. L., Byron, K. S., Brewster, F. E. and Purtilo, D. T. 1980. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science210:543.","DOI":"10.1126\/science.6158759"},{"key":"key\n\t\t\t\t20170710085140_R16","doi-asserted-by":"crossref","unstructured":"Nguyen, K. B. and Biron, C. A. 1999. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J. Immunol.162:5238.","DOI":"10.4049\/jimmunol.162.9.5238"},{"key":"key\n\t\t\t\t20170710085140_R17","doi-asserted-by":"crossref","unstructured":"Pien, G. C. and Biron, C. A. 2000. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J. Immunol. 164: in press.","DOI":"10.4049\/jimmunol.164.2.994"},{"key":"key\n\t\t\t\t20170710085140_R18","unstructured":"Orange, J. S. and Biron, C. A. 1996. Characterization of early IL-12, IFN-\u03b1\u03b2, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol.156:4746."},{"key":"key\n\t\t\t\t20170710085140_R19","unstructured":"Current Protocols in Immunology, chapter 3. 1999. John Wiley, & Sons, Inc."},{"key":"key\n\t\t\t\t20170710085140_R20","unstructured":"Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L. and Phillips, J. H. 1999. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol.162:6981."},{"key":"key\n\t\t\t\t20170710085140_R21","doi-asserted-by":"crossref","unstructured":"Poy, F., Yaffe, M. B., Sayos, J., Saxena, K., Morra, M., Sumegi, J., Cantley, L. C., Terhorst, C. and Eck, M. J. 1999. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell4:555.","DOI":"10.1016\/S1097-2765(00)80206-3"},{"key":"key\n\t\t\t\t20170710085140_R22","doi-asserted-by":"crossref","unstructured":"Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol.17:189.","DOI":"10.1146\/annurev.immunol.17.1.189"},{"key":"key\n\t\t\t\t20170710085140_R23","doi-asserted-by":"crossref","unstructured":"Trinchieri, G. 1998. Immunobiology of interleukin-12. Immunol. Res.17:269.","DOI":"10.1007\/BF02786451"},{"key":"key\n\t\t\t\t20170710085140_R24","doi-asserted-by":"crossref","unstructured":"Yoshimoto, T., Nagase, H., Yoneto, T., Inoue, J.-i. and Nariuchi, H. 1998. Interleukin-12 expression in B cells by transformation with Epstein-Barr virus. Biochem. Biophys. Res. Commun.252:556.","DOI":"10.1006\/bbrc.1998.9693"},{"key":"key\n\t\t\t\t20170710085140_R25","doi-asserted-by":"crossref","unstructured":"Mathew, P. A., Garni-Wagner, B. A., Land, K. ,Takashima, A., Stoneman, E., Bennett, M. and Kumar, V. 1993. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol.151:5328.","DOI":"10.4049\/jimmunol.151.10.5328"},{"key":"key\n\t\t\t\t20170710085140_R26","doi-asserted-by":"crossref","unstructured":"Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M. and Kumar, V. 1993. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol.151:60.","DOI":"10.4049\/jimmunol.151.1.60"},{"key":"key\n\t\t\t\t20170710085140_R27","doi-asserted-by":"crossref","unstructured":"Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A. and Barclay, A. N. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med.188:2083.","DOI":"10.1084\/jem.188.11.2083"},{"key":"key\n\t\t\t\t20170710085140_R28","doi-asserted-by":"crossref","unstructured":"Peritt, D., Sesok-Pizzini, D. A., Schretzenmair, R., Macgregor, R. R., Valiante, N. M., Tu, X., Trinchieri, G. and Kamoun, M. 1999. C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease. J. Immunol.162:7563.","DOI":"10.4049\/jimmunol.162.12.7563"},{"key":"key\n\t\t\t\t20170710085140_R29","doi-asserted-by":"crossref","unstructured":"Latchman, Y., McKay, P. F. and Reiser, H. 1998. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol.161:5809.","DOI":"10.4049\/jimmunol.161.11.5809"},{"key":"key\n\t\t\t\t20170710085140_R30","doi-asserted-by":"crossref","unstructured":"Fisher, R. C. and Thorley-Lawson, D. A. 1991. Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48). Mol. Cell. Biol.11:1614.","DOI":"10.1128\/MCB.11.3.1614"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/12\/12\/1749\/18318873\/121749.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T04:38:44Z","timestamp":1682224724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article-lookup\/doi\/10.1093\/intimm\/12.12.1749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2000,12]]},"published-print":{"date-parts":[[2000,12]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/12.12.1749","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}